← All diseases
Cancer
Anaplastic thyroid carcinoma
Would you like to receive a message when there is new research about Anaplastic Thyroid Carcinoma? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence appears above each publication explaining what was studied — and you'll be notified as soon as there is new research about Anaplastic Thyroid Carcinoma. View what Premium costs.
Publications and studies (1124)
- Anaplastic Cancer: Our Experience. (2022/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Anaplastic Transformation of Follicular Thyroid Carcinoma in Pulmonary Metastasis With Gradually Progressive Intra-tumoral Cavitation: A Case Report. (2022/11/29) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Synchronous mucoepidermoid carcinoma and papillary microcarcinomas of the thyroid gland. (2022/11/22) ♡
- MMP1 acts as a potential regulator of tumor progression and dedifferentiation in papillary thyroid cancer. (2022/11/21) ♡
- Dual Inhibition of BRAF-MAPK and STAT3 Signaling Pathways in Resveratrol-Suppressed Anaplastic Thyroid Cancer Cells with BRAF Mutations. (2022/11/19) ♡
- EIF1AX mutation in thyroid tumors: a retrospective analysis of cytology, histopathology and co-mutation profiles. (2022/11/12) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Clinical Outcomes of Different Treatment Modalities in Anaplastic Thyroid Cancer: A Single Center Experience. (2022/11/01) ♡
- MiR-200c regulates invasion, proliferation and EMT of anaplastic thyroid cancer cells by targeting parathyroid hormone like hormone. (2022/11/01) ♡
- Management of anaplastic thyroid cancer and proposed treatment guidelines-A 5-year case series study. (2022/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Evaluating new treatments for anaplastic thyroid cancer. (2022/11/01) ♡
- Inhibition of Glycogen Metabolism Induces Reactive Oxygen Species-Dependent Cytotoxicity in Anaplastic Thyroid Cancer in Female Mice. (2022/10/23) ♡
- Evaluation of anaplastic thyroid carcinoma in the Kurdistan region of Iraq. (2022/10/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Rationale Efficacy and Safety Evidence of Lenvatinib and Pembrolizumab Association in Anaplastic Thyroid Carcinoma. (2022/10/14) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model. (2022/10/11) ♡
- CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment. (2022/10/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Aggressive variants of follicular cell-derived thyroid carcinoma: an overview. (2022/10/01) ♡
- RNA-Seq transcriptome analysis reveals Maackia amurensis leukoagglutinin has antitumor activity in human anaplastic thyroid cancer cells. (2022/10/01) ♡
- Five-year relative survival and determinants of excess mortality in patients with head and neck and thyroid cancers: A population-based study from Golestan province, Northern Iran. (2022/10/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Durable response of anaplastic thyroid carcinoma to FS118, a bispecific LAG-3/PD-L1 antibody, after checkpoint inhibitor progression: a case report. (2022/10/01) ♡
- Core Needle Biopsy in Suspicious Malignant Thyroid Nodules with Repeated Nondiagnostic Fine Needle Aspiration. (2022/10/01) ♡
- Ga-68 Prostate-Specific Membrane Antigen-HBED-CC Positron Emission Tomography/Computed Tomography in Anaplastic Thyroid Carcinoma. (2022/10/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Role of m6A RNA Methylation in Thyroid Cancer Cell Lines. (2022/09/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Optical diagnostic imaging and therapy for thyroid cancer. (2022/09/26) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Effectiveness of core needle biopsy in the diagnosis of thyroid lymphoma and anaplastic thyroid carcinoma: A systematic review and meta-analysis. (2022/09/20) ♡
- What to do when advanced thyroid cancer invades the carotid artery? Therapeutic challenge. (2022/09/19) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Molecular mechanisms of resistance to kinase inhibitors and redifferentiation in thyroid cancers. (2022/09/14) ♡
- Inhibiting ERK dimerization ameliorates BRAF-driven anaplastic thyroid cancer. (2022/09/03) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Thyroid cancer harboring PTEN and TP53 mutations: A peculiar molecular and clinical case report. (2022/09/02) ♡
- Impact of radiotherapy on survival in resected or unresectable anaplastic thyroid carcinomas, a Rare Cancer Network study. (2022/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Anticancer effects of natural phytochemicals in anaplastic thyroid cancer (Review). (2022/09/01) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE). (2022/09/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial: The role of genetic alterations in thyroid carcinoma. (2022/08/23) ♡
- Expression of T-cell immunoreceptor with immunoglobulin and tyrosine-based inhibitory motif domains (TIGIT) in anaplastic thyroid carcinoma. (2022/08/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. What is the status of immunotherapy in thyroid neoplasms? (2022/08/05) ♡
- Detection of BRAFV600E by digital PCR on fine-needle aspirate enables rapid initiation of dabrafenib and trametinib in unresectable anaplastic thyroid carcinoma. (2022/08/02) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. "RB-reactivator screening" as a novel cell-based assay for discoveries of molecular targeting agents including the first-in-class MEK inhibitor trametinib (trade name: Mekinist). (2022/08/01) ♡
- Blocking CDK7-Mediated NOTCH1-cMYC Signaling Attenuates Cancer Stem Cell Activity in Anaplastic Thyroid Cancer. (2022/08/01) ♡
- Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients. (2022/08/01) ♡
- Thyroid angiosarcoma: A case report and review of literature. (2022/08/01) ♡
- Anaplastic Thyroid Carcinoma, Squamous Cell Carcinoma Pattern. (2022/08/01) ♡
- Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. (2022/08/01) ♡
- New hope for patients with BRAF V600E-mutant anaplastic thyroid cancer: lights and shadows. (2022/08/01) ♡
- Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma. (2022/08/01) ♡
- A-Kinase Interacting Protein 1 Knockdown Restores Chemosensitivity via Inactivating PI3K/AKT and β-Catenin Pathways in Anaplastic Thyroid Carcinoma. (2022/07/28) ♡
- Outcomes and Toxicities of Nonmedullary Thyroid Tumors Treated with Proton Beam Radiation Therapy. (2022/07/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects. (2022/07/08) ♡
- Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies. (2022/07/07) ♡
- Risk Factors for Anaplastic Thyroid Carcinoma: A Case Series From a Tertiary Referral Center for Thyroid Surgery and Literature Analysis. (2022/07/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. An Appraisal and Update of Fluorodeoxyglucose and Non-Fluorodeoxyglucose-PET Tracers in Thyroid and Non-Thyroid Endocrine Neoplasms. (2022/07/01) ♡
- BRAF V600E protect from cell death via inhibition of the mitochondrial permeability transition in papillary and anaplastic thyroid cancers. (2022/07/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.